Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. (Q53588126)

From Wikidata
Jump to navigation Jump to search
scientific article published in November 2006
edit
Language Label Description Also known as
English
Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor.
scientific article published in November 2006

    Statements

    Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit